Medicinal plants with anti-colorectal cancer bioactive compounds: Potential game-changers in colorectal cancer management. 2022

John M Macharia, and Ruth W Mwangi, and Nora Rozmann, and Kaposztas Zsolt, and Tímea Varjas, and Paschal O Uchechukwu, and Isabel N Wagara, and Bence L Raposa
Doctoral School of Health Sciences, Faculty of Health Science, University of Pẻcs, Hungary. Electronic address: johnmacharia@rocketmail.com.

Development and identification of molecular compounds capable of killing or inhibiting transformed cells promoting carcinogenesis without inducing toxic effects to the normal cells are of utmost significance. A systematic review was conducted in screening for important literature was extensively performed by searching the Web of Science, Ovid, BMC Springer, Elsevier, Embase, and MEDLINE databases for optimum selectivity. Google Scholar was also used to supplement information. Pharmacotherapeutic biomolecules active against colon cancer carcinogenesis in Musa acuminata and Musa balbisiana (bananas), Punica granatum L (pomegranate), Glycine max (Soybean), Brassica oleracea L var. italica Plenck (Broccoli), and Hibiscus rosa-sinesis and Hibiscus sabdariffa (hibiscus) were evaluated. Signaling pathways like phosphatidylinositol 3-kinase (PI3K), mitogen-activated protein kinase (MAPK), protein kinase B (AKT), and nuclear factor-kappa B (NFκB) correlate the mediation of COX-2 expression. Increased levels of COX-2 are correlated with the occurrence and progression of colon cancer. Natural antioxidants in herbal plants including polyphenols and carotenoids inhibit the oxidation of lipids, proteins, and nucleic acids and thereby preventing the initiation of oxidizing chain reactions. These bioactive compounds should be considered an important dietary supplement.

UI MeSH Term Description Entries

Related Publications

John M Macharia, and Ruth W Mwangi, and Nora Rozmann, and Kaposztas Zsolt, and Tímea Varjas, and Paschal O Uchechukwu, and Isabel N Wagara, and Bence L Raposa
January 2022, Advanced pharmaceutical bulletin,
John M Macharia, and Ruth W Mwangi, and Nora Rozmann, and Kaposztas Zsolt, and Tímea Varjas, and Paschal O Uchechukwu, and Isabel N Wagara, and Bence L Raposa
November 2025, Pharmaceuticals (Basel, Switzerland),
John M Macharia, and Ruth W Mwangi, and Nora Rozmann, and Kaposztas Zsolt, and Tímea Varjas, and Paschal O Uchechukwu, and Isabel N Wagara, and Bence L Raposa
January 2023, Letters in applied microbiology,
John M Macharia, and Ruth W Mwangi, and Nora Rozmann, and Kaposztas Zsolt, and Tímea Varjas, and Paschal O Uchechukwu, and Isabel N Wagara, and Bence L Raposa
January 2021, Progress in the chemistry of organic natural products,
John M Macharia, and Ruth W Mwangi, and Nora Rozmann, and Kaposztas Zsolt, and Tímea Varjas, and Paschal O Uchechukwu, and Isabel N Wagara, and Bence L Raposa
May 2023, Pathology, research and practice,
John M Macharia, and Ruth W Mwangi, and Nora Rozmann, and Kaposztas Zsolt, and Tímea Varjas, and Paschal O Uchechukwu, and Isabel N Wagara, and Bence L Raposa
July 2023, Pathology, research and practice,
John M Macharia, and Ruth W Mwangi, and Nora Rozmann, and Kaposztas Zsolt, and Tímea Varjas, and Paschal O Uchechukwu, and Isabel N Wagara, and Bence L Raposa
May 2023, Pathology, research and practice,
John M Macharia, and Ruth W Mwangi, and Nora Rozmann, and Kaposztas Zsolt, and Tímea Varjas, and Paschal O Uchechukwu, and Isabel N Wagara, and Bence L Raposa
April 2020, Marine drugs,
John M Macharia, and Ruth W Mwangi, and Nora Rozmann, and Kaposztas Zsolt, and Tímea Varjas, and Paschal O Uchechukwu, and Isabel N Wagara, and Bence L Raposa
January 2021, Current pharmaceutical design,
John M Macharia, and Ruth W Mwangi, and Nora Rozmann, and Kaposztas Zsolt, and Tímea Varjas, and Paschal O Uchechukwu, and Isabel N Wagara, and Bence L Raposa
May 2023, Pathology, research and practice,
Copied contents to your clipboard!